Pharmaceutical Surfactants Market Forecast to 2028 - COVID-19 Impact and Global Analysis By Type (Anionic Surfactants, Cationic Surfactants, Non-Ionic Surfactants, Amphoteric Surfactants, Macromolecule Surfactants, Others); Application (Gene Delivery, Intracellular Products Recovery, Antimicrobial Agents, Emulsifying Agents, Probiotic Preparations, Others) and Geography

Report Code: TIPRE00023218 | No. of Pages: 150 | Category: Pharmaceuticals | Status: Upcoming

Covid
Assesing the covid-19 impact?
Get the Latest COVID-19 Analysis on this market
Request Now
Happy to join you in your fight against the COVID-19 economic pandemic!
MARKET OVERVIEW

Surfactants are organic chemicals that are generally used in pharmaceuticals for the recovery of intracellular products and gene delivery. They can be utilized as an antimicrobial agent as they stop the nourishment of various pathogenic microbes such as bacteria, fungi, and viruses, etc., and make the pharmaceutical preparations free of microbes that are harmful. They can be categorized as anionic surfactants, non-ionic surfactants, and many more. The non-ionic surfactants are used for protein formulations in pharmaceuticals. The surfactants are also used for drug delivery, act as an adhesive agent and therapeutic agent. Gemini surfactants are used as a transfection agent for drug delivery and are one of the most active research areas.

MARKET SCOPE

The "Global Pharmaceutical Surfactants Market Analysis to 2028" is a specialized and in-depth study of the healthcare industry with a special focus on the global market trend analysis. The report aims to provide an overview of the pharmaceutical surfactants market with detailed market segmentation by type, application, and geography. The report provides key statistics on the market status of the leading pharmaceutical surfactants market players and offers key trends and opportunities in the market.

MARKET SEGMENTATION

  •  Based on type, the global pharmaceutical surfactants market is segmented into anionic surfactants, cationic surfactants, non-ionic surfactants, amphoteric surfactants, macromolecule surfactants and others.
  •  On the basis of application, the market is segmented into gene delivery, intracellular products recovery, antimicrobial agents, emulsifying agents, probiotic preparations and others.

MARKET DYNAMICS
Drivers

  •   Growing incidences of respiratory distress syndrome and antimicrobial properties of pharmaceutical surfactants are expected to drive the pharmaceutical surfactants market growth.
  •   Increasing respiratory problems in neonates due to the alveolar surfactant deficiency and unique pharmaceutical surfactants property of emulsification and solubilization for protein formulations and drug delivery boost the market growth.
  •   The rising market for these products and increasing application in the cosmetics and medicine field propel market growth.
  •   Growing funding in research and development and clinical trial activities fuel the market growth.

Restraints

  •   Strict regulatory guidelines regarding pharmaceutical surfactants product launch.

REGIONAL FRAMEWORK

The report provides a detailed overview of the industry including both qualitative and quantitative information. It provides an overview and forecast of the global market based on various segments. It also provides market size and forecast estimates from the year 2019 to 2028 with respect to five major regions, namely; North America, Europe, Asia-Pacific (APAC), the Middle East and Africa (MEA), and South America. The pharmaceutical surfactants market by each region is later sub-segmented by respective countries and segments. The report covers the analysis and forecast of 18 countries globally along with the current trend and opportunities prevailing in the region.

The report analyzes factors affecting the market from both demand and supply side and further evaluates market dynamics affecting the market during the forecast period i.e., drivers, restraints, opportunities, and future trend. The report also provides exhaustive PEST analysis for all five regions namely; North America, Europe, APAC, MEA, and South America after evaluating political, economic, social and technological factors affecting the pharmaceutical surfactants market in these regions.

IMPACT OF COVID-19 ON PHARMACEUTICAL SURFACTANTS MARKET

COVID-19 first began in Wuhan (China) during December 2019, and since then, it has spread at a fast pace across the globe. The US, India, Brazil, Russia, France, UK, Turkey, Italy, and Spain are some of the worst affected countries in terms of confirmed cases and reported deaths. Due to the COVID-19 outbreak, the country-wise lockdown was imposed with self-quarantine regulations, the supply chain was disrupted, and the market registered a certain level of decline in growth. As the biosurfactants have been found to act as effective drug delivery systems and maintain dose proportionality in the process. Finally, the potential of biosurfactants to exhibit medicinal qualities in the treatment of SARS-CoV-2 infection has increased its demand, and because of the removal of restrictive measures, the surfactants market may witness growth in coming years.



Get more information on this report :

MARKET PLAYERS


The report covers key developments in the pharmaceutical surfactants market as organic and inorganic growth strategies. Various companies are focusing on organic growth strategies such as product launches, product approvals and others such as patents and events. Inorganic growth strategies activities witnessed in the market were acquisitions, and partnership & collaborations. These activities have paved way for the expansion of business and customer base of market players. The market players from pharmaceutical surfactants market are anticipated to have lucrative growth opportunities in the future with the rising demand for pharmaceutical surfactants in the global market.

The report also includes the profiles of key companies along with their SWOT analysis and market strategies in the pharmaceutical surfactants market. In addition, the report focuses on leading industry players with information such as company profiles, components, and services offered, financial information of the last 3 years, the key development in the past five years.

  •  Akzo Nobel N.V.
  •  Evonik
  •  Croda International Plc.
  •  BASF SE
  •  Dow Chemical Company
  •  Jeneil Biotech
  •  Soliance, S.A.
  •  Ecover
  •  Ashland Global Holdings, Inc.
  •  Wacker Chemie AG

The Insight Partner's dedicated research and analysis team consist of experienced professionals with advanced statistical expertise and offer various customization options in the existing study.


Get more information on this report :

TABLE OF CONTENTS

1. INTRODUCTION
1.1. SCOPE OF THE STUDY
1.2. THE INSIGHT PARTNERS RESEARCH REPORT GUIDANCE
1.3. MARKET SEGMENTATION
1.3.1 Pharmaceutical Surfactants Market - By Type
1.3.2 Pharmaceutical Surfactants Market - By Application
1.3.3 Pharmaceutical Surfactants Market - By Region
1.3.3.1 By Country

2. KEY TAKEAWAYS

3. RESEARCH METHODOLOGY

4. PHARMACEUTICAL SURFACTANTS MARKET LANDSCAPE
4.1. OVERVIEW
4.2. PORTER'S FIVE FORCES ANALYSIS
4.2.1 Bargaining Power of Buyers
4.2.1 Bargaining Power of Suppliers
4.2.1 Threat of Substitute
4.2.1 Threat of New Entrants
4.2.1 Competitive Rivalry
4.3. EXPERT OPINIONS

5. PHARMACEUTICAL SURFACTANTS MARKET - KEY MARKET DYNAMICS
5.1. KEY MARKET DRIVERS
5.2. KEY MARKET RESTRAINTS
5.3. KEY MARKET OPPORTUNITIES
5.4. FUTURE TRENDS
5.5. IMPACT ANALYSIS OF DRIVERS AND RESTRAINTS

6. PHARMACEUTICAL SURFACTANTS MARKET - GLOBAL MARKET ANALYSIS
6.1. PHARMACEUTICAL SURFACTANTS - GLOBAL MARKET OVERVIEW
6.2. PHARMACEUTICAL SURFACTANTS - GLOBAL MARKET AND FORECAST TO 2028
6.3. MARKET POSITIONING/MARKET SHARE

7. PHARMACEUTICAL SURFACTANTS MARKET - REVENUE AND FORECASTS TO 2028 - TYPE
7.1. OVERVIEW
7.2. TYPE MARKET FORECASTS AND ANALYSIS
7.3. ANIONIC SURFACTANTS
7.3.1. Overview
7.3.2. Anionic Surfactants Market Forecast and Analysis
7.4. CATIONIC SURFACTANTS
7.4.1. Overview
7.4.2. Cationic Surfactants Market Forecast and Analysis
7.5. NON-IONIC SURFACTANTS
7.5.1. Overview
7.5.2. Non-Ionic Surfactants Market Forecast and Analysis
7.6. AMPHOTERIC SURFACTANTS
7.6.1. Overview
7.6.2. Amphoteric Surfactants Market Forecast and Analysis
7.7. MACROMOLECULE SURFACTANTS
7.7.1. Overview
7.7.2. Macromolecule Surfactants Market Forecast and Analysis
7.8. OTHERS
7.8.1. Overview
7.8.2. Others Market Forecast and Analysis
8. PHARMACEUTICAL SURFACTANTS MARKET - REVENUE AND FORECASTS TO 2028 - APPLICATION
8.1. OVERVIEW
8.2. APPLICATION MARKET FORECASTS AND ANALYSIS
8.3. GENE DELIVERY
8.3.1. Overview
8.3.2. Gene Delivery Market Forecast and Analysis
8.4. INTRACELLULAR PRODUCTS RECOVERY
8.4.1. Overview
8.4.2. Intracellular Products Recovery Market Forecast and Analysis
8.5. ANTIMICROBIAL AGENTS
8.5.1. Overview
8.5.2. Antimicrobial Agents Market Forecast and Analysis
8.6. EMULSIFYING AGENTS
8.6.1. Overview
8.6.2. Emulsifying Agents Market Forecast and Analysis
8.7. PROBIOTIC PREPARATIONS
8.7.1. Overview
8.7.2. Probiotic Preparations Market Forecast and Analysis
8.8. OTHERS
8.8.1. Overview
8.8.2. Others Market Forecast and Analysis

9. PHARMACEUTICAL SURFACTANTS MARKET REVENUE AND FORECASTS TO 2028 - GEOGRAPHICAL ANALYSIS
9.1. NORTH AMERICA
9.1.1 North America Pharmaceutical Surfactants Market Overview
9.1.2 North America Pharmaceutical Surfactants Market Forecasts and Analysis
9.1.3 North America Pharmaceutical Surfactants Market Forecasts and Analysis - By Type
9.1.4 North America Pharmaceutical Surfactants Market Forecasts and Analysis - By Application
9.1.5 North America Pharmaceutical Surfactants Market Forecasts and Analysis - By Countries
9.1.5.1 Canada Pharmaceutical Surfactants Market
9.1.5.1.1 Canada Pharmaceutical Surfactants Market by Type
9.1.5.1.2 Canada Pharmaceutical Surfactants Market by Application
9.1.5.2 Mexico Pharmaceutical Surfactants Market
9.1.5.2.1 Mexico Pharmaceutical Surfactants Market by Type
9.1.5.2.2 Mexico Pharmaceutical Surfactants Market by Application
9.1.5.3 US Pharmaceutical Surfactants Market
9.1.5.3.1 US Pharmaceutical Surfactants Market by Type
9.1.5.3.2 US Pharmaceutical Surfactants Market by Application
9.2. EUROPE
9.2.1 Europe Pharmaceutical Surfactants Market Overview
9.2.2 Europe Pharmaceutical Surfactants Market Forecasts and Analysis
9.2.3 Europe Pharmaceutical Surfactants Market Forecasts and Analysis - By Type
9.2.4 Europe Pharmaceutical Surfactants Market Forecasts and Analysis - By Application
9.2.5 Europe Pharmaceutical Surfactants Market Forecasts and Analysis - By Countries
9.2.5.1 Germany Pharmaceutical Surfactants Market
9.2.5.1.1 Germany Pharmaceutical Surfactants Market by Type
9.2.5.1.2 Germany Pharmaceutical Surfactants Market by Application
9.2.5.2 France Pharmaceutical Surfactants Market
9.2.5.2.1 France Pharmaceutical Surfactants Market by Type
9.2.5.2.2 France Pharmaceutical Surfactants Market by Application
9.2.5.3 Italy Pharmaceutical Surfactants Market
9.2.5.3.1 Italy Pharmaceutical Surfactants Market by Type
9.2.5.3.2 Italy Pharmaceutical Surfactants Market by Application
9.2.5.4 Spain Pharmaceutical Surfactants Market
9.2.5.4.1 Spain Pharmaceutical Surfactants Market by Type
9.2.5.4.2 Spain Pharmaceutical Surfactants Market by Application
9.2.5.5 United Kingdom Pharmaceutical Surfactants Market
9.2.5.5.1 United Kingdom Pharmaceutical Surfactants Market by Type
9.2.5.5.2 United Kingdom Pharmaceutical Surfactants Market by Application
9.2.5.6 Rest of Europe Pharmaceutical Surfactants Market
9.2.5.6.1 Rest of Europe Pharmaceutical Surfactants Market by Type
9.2.5.6.2 Rest of Europe Pharmaceutical Surfactants Market by Application
9.3. ASIA-PACIFIC
9.3.1 Asia-Pacific Pharmaceutical Surfactants Market Overview
9.3.2 Asia-Pacific Pharmaceutical Surfactants Market Forecasts and Analysis
9.3.3 Asia-Pacific Pharmaceutical Surfactants Market Forecasts and Analysis - By Type
9.3.4 Asia-Pacific Pharmaceutical Surfactants Market Forecasts and Analysis - By Application
9.3.5 Asia-Pacific Pharmaceutical Surfactants Market Forecasts and Analysis - By Countries
9.3.5.1 Australia Pharmaceutical Surfactants Market
9.3.5.1.1 Australia Pharmaceutical Surfactants Market by Type
9.3.5.1.2 Australia Pharmaceutical Surfactants Market by Application
9.3.5.2 China Pharmaceutical Surfactants Market
9.3.5.2.1 China Pharmaceutical Surfactants Market by Type
9.3.5.2.2 China Pharmaceutical Surfactants Market by Application
9.3.5.3 India Pharmaceutical Surfactants Market
9.3.5.3.1 India Pharmaceutical Surfactants Market by Type
9.3.5.3.2 India Pharmaceutical Surfactants Market by Application
9.3.5.4 Japan Pharmaceutical Surfactants Market
9.3.5.4.1 Japan Pharmaceutical Surfactants Market by Type
9.3.5.4.2 Japan Pharmaceutical Surfactants Market by Application
9.3.5.5 South Korea Pharmaceutical Surfactants Market
9.3.5.5.1 South Korea Pharmaceutical Surfactants Market by Type
9.3.5.5.2 South Korea Pharmaceutical Surfactants Market by Application
9.3.5.6 Rest of Asia-Pacific Pharmaceutical Surfactants Market
9.3.5.6.1 Rest of Asia-Pacific Pharmaceutical Surfactants Market by Type
9.3.5.6.2 Rest of Asia-Pacific Pharmaceutical Surfactants Market by Application
9.4. MIDDLE EAST AND AFRICA
9.4.1 Middle East and Africa Pharmaceutical Surfactants Market Overview
9.4.2 Middle East and Africa Pharmaceutical Surfactants Market Forecasts and Analysis
9.4.3 Middle East and Africa Pharmaceutical Surfactants Market Forecasts and Analysis - By Type
9.4.4 Middle East and Africa Pharmaceutical Surfactants Market Forecasts and Analysis - By Application
9.4.5 Middle East and Africa Pharmaceutical Surfactants Market Forecasts and Analysis - By Countries
9.4.5.1 South Africa Pharmaceutical Surfactants Market
9.4.5.1.1 South Africa Pharmaceutical Surfactants Market by Type
9.4.5.1.2 South Africa Pharmaceutical Surfactants Market by Application
9.4.5.2 Saudi Arabia Pharmaceutical Surfactants Market
9.4.5.2.1 Saudi Arabia Pharmaceutical Surfactants Market by Type
9.4.5.2.2 Saudi Arabia Pharmaceutical Surfactants Market by Application
9.4.5.3 U.A.E Pharmaceutical Surfactants Market
9.4.5.3.1 U.A.E Pharmaceutical Surfactants Market by Type
9.4.5.3.2 U.A.E Pharmaceutical Surfactants Market by Application
9.4.5.4 Rest of Middle East and Africa Pharmaceutical Surfactants Market
9.4.5.4.1 Rest of Middle East and Africa Pharmaceutical Surfactants Market by Type
9.4.5.4.2 Rest of Middle East and Africa Pharmaceutical Surfactants Market by Application
9.5. SOUTH AND CENTRAL AMERICA
9.5.1 South and Central America Pharmaceutical Surfactants Market Overview
9.5.2 South and Central America Pharmaceutical Surfactants Market Forecasts and Analysis
9.5.3 South and Central America Pharmaceutical Surfactants Market Forecasts and Analysis - By Type
9.5.4 South and Central America Pharmaceutical Surfactants Market Forecasts and Analysis - By Application
9.5.5 South and Central America Pharmaceutical Surfactants Market Forecasts and Analysis - By Countries
9.5.5.1 Brazil Pharmaceutical Surfactants Market
9.5.5.1.1 Brazil Pharmaceutical Surfactants Market by Type
9.5.5.1.2 Brazil Pharmaceutical Surfactants Market by Application
9.5.5.2 Argentina Pharmaceutical Surfactants Market
9.5.5.2.1 Argentina Pharmaceutical Surfactants Market by Type
9.5.5.2.2 Argentina Pharmaceutical Surfactants Market by Application
9.5.5.3 Rest of South and Central America Pharmaceutical Surfactants Market
9.5.5.3.1 Rest of South and Central America Pharmaceutical Surfactants Market by Type
9.5.5.3.2 Rest of South and Central America Pharmaceutical Surfactants Market by Application

10. INDUSTRY LANDSCAPE
10.1. MERGERS AND ACQUISITIONS
10.2. AGREEMENTS, COLLABORATIONS AND JOIN VENTURES
10.3. NEW PRODUCT LAUNCHES
10.4. EXPANSIONS AND OTHER STRATEGIC DEVELOPMENTS

11. PHARMACEUTICAL SURFACTANTS MARKET, KEY COMPANY PROFILES
11.1. AKZO NOBEL N.V.
11.1.1. Key Facts
11.1.2. Business Description
11.1.3. Products and Services
11.1.4. Financial Overview
11.1.5. SWOT Analysis
11.1.6. Key Developments
11.2. EVONIK
11.2.1. Key Facts
11.2.2. Business Description
11.2.3. Products and Services
11.2.4. Financial Overview
11.2.5. SWOT Analysis
11.2.6. Key Developments
11.3. CRODA INTERNATIONAL PLC.
11.3.1. Key Facts
11.3.2. Business Description
11.3.3. Products and Services
11.3.4. Financial Overview
11.3.5. SWOT Analysis
11.3.6. Key Developments
11.4. BASF SE
11.4.1. Key Facts
11.4.2. Business Description
11.4.3. Products and Services
11.4.4. Financial Overview
11.4.5. SWOT Analysis
11.4.6. Key Developments
11.5. DOW CHEMICAL COMPANY
11.5.1. Key Facts
11.5.2. Business Description
11.5.3. Products and Services
11.5.4. Financial Overview
11.5.5. SWOT Analysis
11.5.6. Key Developments
11.6. JENEIL BIOTECH
11.6.1. Key Facts
11.6.2. Business Description
11.6.3. Products and Services
11.6.4. Financial Overview
11.6.5. SWOT Analysis
11.6.6. Key Developments
11.7. SOLIANCE, S.A.
11.7.1. Key Facts
11.7.2. Business Description
11.7.3. Products and Services
11.7.4. Financial Overview
11.7.5. SWOT Analysis
11.7.6. Key Developments
11.8. ECOVER
11.8.1. Key Facts
11.8.2. Business Description
11.8.3. Products and Services
11.8.4. Financial Overview
11.8.5. SWOT Analysis
11.8.6. Key Developments
11.9. ASHLAND GLOBAL HOLDINGS, INC.
11.9.1. Key Facts
11.9.2. Business Description
11.9.3. Products and Services
11.9.4. Financial Overview
11.9.5. SWOT Analysis
11.9.6. Key Developments
11.10. WACKER CHEMIE AG
11.10.1. Key Facts
11.10.2. Business Description
11.10.3. Products and Services
11.10.4. Financial Overview
11.10.5. SWOT Analysis
11.10.6. Key Developments

12. APPENDIX
12.1. ABOUT THE INSIGHT PARTNERS
12.2. GLOSSARY OF TERMS
The List of Companies

1. Akzo Nobel N.V.
2. Evonik
3. Croda International Plc.
4. BASF SE
5. Dow Chemical Company
6. Jeneil Biotech
7. Soliance, S.A.
8. Ecover
9. Ashland Global Holdings, Inc.
10. Wacker Chemie AG
TIPRE00023218
Your data will never be shared with third parties, however, we may send you information from time to time about our products that may be of interest to you. By submitting your details, you agree to be contacted by us. You may contact us at any time to opt-out.

Pricing

Free

20%

customization on Pre-Booking